HSCL2024-01-012024-03-31 HSCL2024-01-012024-03-31 HSCL2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member HSCL2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member HSCL2024-03-31 HSCL2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue01Member HSCL2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue02Member HSCL2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue01Member HSCL2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue02Member HSCL2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults01Member HSCL2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults02Member HSCL2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults01Member HSCL2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults02Member HSCL2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets01Member HSCL2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets02Member HSCL2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities01Member HSCL2024-03-31in-bse-fin:OneReportableSegmentLiabilities01Member HSCL2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities02Member HSCL2024-03-31in-bse-fin:OneReportableSegmentLiabilities02Member HSCL2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member HSCL2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member HSCL2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member HSCL2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member HSCL2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member HSCL2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500184 HSCL NA Himadri Speciality Chemical Limited Equity 2023-04-01 2024-03-31 2024-04-25 2024-04-18 INR Crores Yearly 12:30:00 15:40:00 2024-04-25 2024-04-25 true Cash Flow Indirect Declaration of unmodified opinion Multi segment 2024-01-01 2024-03-31 Audited Consolidated 11769500000.00 123900000.00 11893400000.00 8336600000.00 0.00 167100000.00 295900000.00 135500000.00 126100000.00 1174900000.00 10236100000.00 1657300000.00 0.00 1657300000.00 295500000.00 210000000.00 505500000.00 0.00 1151800000.00 0.00 0.00 0.00 0.00 1151800000.00 -11200000.00 1140600000.00 1151600000.00 200000.00 1139900000.00 700000.00 492600000.00 1 2.41 2.41 0.00 0.00 2.41 2.41 (2) The above audited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 25 April 2024. (3) Other expenses includes foreign exchange fluctuation loss/ (gain) (net) of Re (0.65) crore for the quarter ended 31 March 2024, Rs (3.71) crores for the quarter ended 31 December 2023, Rs (3.54) crores for the quarter ended 31 March 2023, Rs (9.68) crores for the year ended 31 March 2024 and Rs 19.80 crores for the year ended 31 March 2023. Finance cost includes exchange difference regarded as an adjustment to borrowing costs in accordance with Ind AS 23, of Re 0.49 crore for the quarter ended 31 March 2024, Re 0.52 crore for the quarter ended 31 December 2023, Re (0.90) crore for the quarter ended 31 March 2023, Rs 3.12 crores for the year ended 31 March 2024 and Rs 13.50 crores for the year ended 31 March 2023. (4) Based on the guiding principles given in Ind AS 108 on 'Operating Segments', the Group's business activity falls within two operating segments, namely: (a) Carbon materials and chemicals, and (b) Power (5) The consolidated financial results are prepared in accordance with the principles and procedures for the preparation and presentation of consolidated financial results as set out in Ind AS 110 'Consolidated Financial Statements' notified by Ministry of Corporate Affairs. The consolidated financial results of Himadri Speciality Chemical Limited (the Holding Company or the Parent), include its subsidiaries, namely AAT Global Limited, Shandong Dawn Himadri Chemical Industry Limited and Combe Projects Private Limited (w.e.f 20 July 2023), Himadri Clean Energy Limited (w.e.f 30 November 2023), Himadri Future Material Technology Limited (w.e.f 01 February 2024) (the Holding Company or the Parent and its subsidiaries together referred to as the 'Group'), combined on a line-by-line basis by adding together the book values of like items of asset and liabilities, income and expenses eliminating intra-group balances and transactions and resulting unrealised gains/ (losses). The consolidated financial results are prepared applying uniform accounting policies on all material items. (6) During the previous year, the Holding Company had issued and allotted 72,550,000 warrants, each convertible into one equity share of Re 1 each, on Preferential allotment basis at an issue price of Rs 70 per warrant, to the Promoter/ Promoter Group of the Holding Company and certain identified non-promoter persons / entity, upon receipt of 25% of the issue price (i.e. Rs 17.50 per warrant) as warrant subscription money. Balance 75% of the issue price (i.e. Rs 52.50 per warrant) was payable within 18 months from the date of allotment i.e.22 August 2022, at the time of exercising the option to apply for fully paid-up equity share of Re 1 each of the Holding Company, against each warrant held by the warrant holder. During the quarter ended 31 March 2024, the Holding Company upon receipt of balance 75% of the issue price (i.e., Rs 52.50 per warrant) for remaining 51,900,000 warrants, has allotted equal no. of fully paid-up equity shares against conversion of said warrants exercised by the warrant holder. As a result of such allotment, the paid-up equity share capital of the Holding Company has increased from 440,694,573 equity shares to 492,594,573 equity shares of face value of Re 1 each. Multi segment 2023-04-01 2024-03-31 Audited Consolidated 41848900000.00 425200000.00 42274100000.00 30669700000.00 0.00 -367000000.00 1104800000.00 638700000.00 498600000.00 3990700000.00 36535500000.00 5738600000.00 0.00 5738600000.00 1010700000.00 621100000.00 1631800000.00 0.00 4106800000.00 0.00 0.00 0.00 0.00 4106800000.00 464900000.00 4571700000.00 4107700000.00 -900000.00 4571500000.00 200000.00 492600000.00 1 29963200000.00 9.16 9.16 0.00 0.00 9.16 9.16 Other Expenses 1174900000.00 Other Expenses 3990700000.00 -27900000.00 15102200000.00 665200000.00 0.00 0.00 237600000.00 0.00 0.00 0.00 4767200000.00 101800000.00 0.00 238700000.00 5107700000.00 73300000.00 232200000.00 21418200000.00 7025200000.00 8200000.00 6556500000.00 2148800000.00 5165300000.00 14000000.00 287600000.00 14180400000.00 0.00 1864100000.00 23069700000.00 44487900000.00 492600000.00 29963200000.00 30455800000.00 30427900000.00 215400000.00 33600000.00 249000000.00 90000000.00 1691300000.00 0.00 0.00 2030300000.00 5788800000.00 5703600000.00 266400000.00 11758800000.00 173800000.00 11000000.00 86100000.00 12029700000.00 14060000000.00 44487900000.00 (7) The consolidated figures for the three months ended 31 March 2024 and the corresponding three months ended 31 March 2023 in the previous year as reported in these consolidated financial results are the balancing figures between audited figures in respect of the full financial year and the published year to date consolidated figures up to the end of the nine months of the relevant financial year. Also the consolidated figures up to the third quarter had only been reviewed and not subjected to audit. (8) The Nomination and Remuneration Committee of the Holding Company at its meeting held on 23 April 2024, has allotted 124,115 equity shares of Re 1 each (Under Grant I: 2,090 equity shares and under Grant II: 122,025 equity shares) to the option grantees pursuant to exercise of options under the Holding Company’s “Himadri Employee Stock Option Plan 2016”. As a result of such allotment, the paid up equity share capital of the Holding Company has increased from 492,594,573 equity shares to 492,718,688 equity shares of face value of Re 1 each. The above does not have any impact on the financial results of the Group. (9) The Board of Directors has recommended a dividend at the rate of Re 0.50 per equity share of Re 1 each (i.e. 50% of face value of equity share) aggregating to Rs 24.64 crores for the year ended 31 March 2024. The payment of dividend is subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Holding Company. (10) Earnings per share is not annualised for the quarter ended 31 March 2024, 31 December 2023 and 31 March 2023. (A) Carbon materials and chemicals 11703100000.00 (B) Power 205700000.00 (A) Carbon materials and chemicals 41610300000.00 (B) Power 1000100000.00 11908800000.00 42610400000.00 139300000.00 761500000.00 11769500000.00 41848900000.00 (A) Carbon materials and chemicals 1490000000.00 (B) Power 172400000.00 (A) Carbon materials and chemicals 4970400000.00 (B) Power 884900000.00 1662400000.00 5855300000.00 135500000.00 638700000.00 -130400000.00 Other unallocable expenses net of unallocable income includes other income, foreign exchange loss/ (gain) (net), and exceptional items fully unallocable -522000000.00 1657300000.00 5738600000.00 (A) Carbon materials and chemicals 30853900000.00 (B) Power 1072900000.00 31926800000.00 12561100000.00 44487900000.00 (A) Carbon materials and chemicals 6229000000.00 (B) Power 4800000.00 6233800000.00 7826200000.00 14060000000.00 638700000.00 -1583000000.00 -1503300000.00 0.00 0.00 500000.00 0.00 -20400000.00 0.00 2237600000.00 0.00 -608000000.00 0.00 498600000.00 0.00 0.00 0.00 -39500000.00 0.00 -51700000.00 0.00 361500000.00 0.00 -11100000.00 0.00 0.00 0.00 40500000.00 0.00 -762600000.00 4976000000.00 0.00 0.00 0.00 928500000.00 0.00 4047500000.00 0.00 0.00 1373600000.00 4215100000.00 0.00 0.00 0.00 0.00 1100000.00 523600000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3900000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 314500000.00 0.00 -995200000.00 0.00 -4048600000.00 0.00 0.00 76800000.00 3110600000.00 0.00 0.00 0.00 0.00 27000000.00 2427900000.00 0.00 14700000.00 108200000.00 629200000.00 0.00 37500000.00 71900000.00 70800000.00 0.00 70800000.00 2078000000.00 2148800000.00 Remeasurements of the net defined benefit plan -4500000.00 Net gain/ (loss) on investment in equity instruments accounted at fair value -400000.00 Remeasurements of the net defined benefit plan -6000000.00 Net gain/ (loss) on investment in equity instruments accounted at fair value 603500000.00 -4900000.00 597500000.00 -1600000.00 130600000.00 Exchange differences in translating financial statements of foreign operations -7900000.00 Exchange differences in translating financial statements of foreign operations -2000000.00 -7900000.00 -2000000.00 0.00 0.00